Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
Hydar El Jamaly, Guy D Eslick, Martin Weltman
Clin Mol Hepatol. 2022;28(1):52-66.   Published online 2021 Sep 17     DOI:
Citations to this article as recorded by Crossref logo
Evaluation of Liver Disease in Pregnancy
Gres Karim, Dewan Giri, Tatyana Kushner, Nancy Reau
Clinics in Liver Disease.2023; 27(1): 133.     CrossRef
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clinical and Molecular Hepatology.2022; 28(1): 47.     CrossRef
Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
Ja-Young Kwon
Clinical and Molecular Hepatology.2022; 28(1): 50.     CrossRef
Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study
Seung Mi Lee, Geum Joon Cho, Won Young Wi, Errol R. Norwitz, Bo Kyung Koo, Jeesun Lee, Young Mi Jung, Soo Heon Kwak, Chan-Wook Park, Jong Kwan Jun, Sae Kyung Joo, Min-Jeong Oh, Won Kim, Joong Shin Park
Hepatology International.2022;[Epub]     CrossRef